We are live on ! Find out more
TSC

Two Seas Capital Portfolio holdings

AUM $7.15B
1-Year Est. Return 169.27%
This Fund
S&P 500
This Quarter Est. Return
+27.23%
1 Year Est. Return
+169.27%
3 Year Est. Return
+279.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$511M
AUM Growth
+$101M
Cap. Flow
+$3.17M
Cap. Flow %
0.62%
Top 10 Hldgs %
94.81%
Holding
22
New
9
Increased
3
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
CORZ icon
Core Scientific
CORZ
+$13.3M
2
IMVT icon
Immunovant
IMVT
+$12.5M
3
VST icon
Vistra
VST
+$9.76M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$6.04M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$4.74M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$15.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$10.5M
3
ESPR
Esperion Therapeutics
ESPR
+$8.55M
4
ROIV icon
Roivant Sciences
ROIV
+$6.23M
5
ABUS icon
Arbutus Biopharma
ABUS
+$3.11M

Sector Composition

Rank Sector Weight
1 Healthcare 84.97%
2 Technology 4.16%
3 Communication Services 3.76%
4 Utilities 2.69%
5 Materials 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDV icon
1
Indivior Pharmaceuticals
INDV
$4.58B
$284M 55.6%
13,251,002
-559,891
-4% -$10.5M
ROIV icon
2
Roivant Sciences
ROIV
$25B
$83.6M 16.37%
7,930,349
-577,874
-7% -$6.23M
ABUS icon
3
Arbutus Biopharma
ABUS
$913M
$20.2M 3.96%
7,841,927
-1,200,000
-13% -$3.11M
IMVT icon
4
Immunovant
IMVT
$8.06B
$17.5M 3.43%
541,295
+342,543
+172% +$12.5M
META icon
5
Meta Platforms (Facebook)
META
$1.5T
$15.5M 3.04%
31,958
+5,783
+22% +$2.58M
VST icon
6
Vistra
VST
$47.4B
$13.7M 2.69%
+197,353
New +$9.76M
CORZ icon
7
Core Scientific
CORZ
$7B
$13.6M 2.66%
+3,830,967
New +$13.3M
ESPR
8
DELISTED
Esperion Therapeutics
ESPR
$11.2M 2.19%
4,165,657
-3,520,463
-46% -$8.55M
ARQT icon
9
Arcutis Biotherapeutics
ARQT
$3.39B
$8.02M 1.57%
+809,332
New +$6.04M
SONO icon
10
Sonos
SONO
$1.88B
$7.69M 1.51%
403,653
+223,921
+125% +$3.97M
AVDL
11
DELISTED
Avadel Pharmaceuticals
AVDL
$5.38M 1.05%
+318,240
New +$4.74M
OMEX icon
12
Odyssey Marine Exploration
OMEX
$43.5M
$4.72M 0.92%
1,237,615
-134,259
-10% -$597K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.43T
$3.68M 0.72%
+24,371
New +$3.49M
SHC icon
14
Sotera Health
SHC
$5.13B
$3.6M 0.71%
+300,000
New +$4.46M
CORZZ icon
15
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.8B
$563K 0.11%
+233,540
New +$574K
TRML
16
DELISTED
Tourmaline Bio
TRML
$501K 0.1%
+21,891
New +$772K
CORZW icon
17
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.48B
$373K 0.07%
+280,248
New +$416K
HTZ icon
18
Hertz
HTZ
$493M
– –
-77,188
Closed -$802K
HTZWW
19
Hertz Global Holdings Warrants
HTZWW
$67.7M
– –
-16,841
Closed -$92.3K
IMVT icon
20
CALL
Immunovant
IMVT
$8.06B
– –
-86,600
Closed -$3.65M
MMM icon
21
3M
MMM
$93.9B
– –
-173,168
Closed -$15.8M

Similar funds

UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Two Seas Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Two Seas Capital held 22 positions worth $511M, up 25% from $410M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Two Seas Capital's Q1 2024 filing shows 9 new, 3 increased, 5 reduced and 4 closed positions. Its largest new stake was Core Scientific: 3,830,967 shares worth $13.6M. The largest sale was 3M, an estimated $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 88% a quarter earlier, followed by Technology and Communication Services.

  • Two Seas Capital's largest Q1 2024 buy was Core Scientific: 3,830,967 shares worth $13.6M.
  • Two Seas Capital added most to Immunovant in Q1 2024, an estimated $12.5M increase.
  • Two Seas Capital's biggest Q1 2024 reduction was Indivior Pharmaceuticals, cutting an estimated $10.5M.
  • Two Seas Capital fully exited 3M in Q1 2024, selling an estimated $15.8M.
  • Two Seas Capital's ten largest holdings make up 95% of its $511M portfolio in Q1 2024.
  • Two Seas Capital opened 9 new positions and closed 4 in Q1 2024.
  • Two Seas Capital's portfolio value rose 25% quarter-over-quarter to $511M.

Based on Two Seas Capital's 13F filing for Q1 2024, filed 15 May 2024.